Salvatore Camilleri

Efficacy of 1 L polyethylene glycol plus ascorbate versus 4 L polyethylene glycol in split-dose for colonoscopy cleansing in out and inpatient: A multicentre, randomized trial (OVER 2019).

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 04, 2023

Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease.

Journal: Journal of gastroenterology and hepatology

Published: January 16, 2023

Predictive Factors of Adequate Bowel Cleansing for Colonoscopy in the Elderly: A Retrospective Analysis of a Prospective Cohort.

Journal: Diagnostics (Basel, Switzerland)

Published: October 19, 2022

Improving the diagnostic approach to celiac disease: Experience from a regional network.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 20, 2021

Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: August 14, 2021

Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 16, 2021

Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).

Journal: Expert opinion on biological therapy

Published: September 28, 2020

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches.

Journal: Inflammatory bowel diseases

Published: December 31, 2019

Efficacy of 1 L polyethylene glycol plus ascorbate versus 4 L polyethylene glycol in split-dose for colonoscopy cleansing in out and inpatient: A multicentre, randomized trial (OVER 2019).

Efficacy of 1 L polyethylene glycol plus ascorbate versus 4 L polyethylene glycol in split-dose for colonoscopy cleansing in out and inpatient: A multicentre, randomized trial (OVER 2019).

Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease.

Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease.

Predictive Factors of Adequate Bowel Cleansing for Colonoscopy in the Elderly: A Retrospective Analysis of a Prospective Cohort.

Predictive Factors of Adequate Bowel Cleansing for Colonoscopy in the Elderly: A Retrospective Analysis of a Prospective Cohort.

Improving the diagnostic approach to celiac disease: Experience from a regional network.

Improving the diagnostic approach to celiac disease: Experience from a regional network.

Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease.

Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease.

Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases.

Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases.

Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).

Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).

Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study.

Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study.

A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease.

A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease.

A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis.

A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis.

Effectiveness of very low-volume preparation for colonoscopy: A prospective, multicenter observational study.

Effectiveness of very low-volume preparation for colonoscopy: A prospective, multicenter observational study.

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches.

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches.